Trial aims to stop deadly gut infection in High-Risk patients
NCT ID NCT05304715
Summary
This study tested if adding the drug bezlotoxumab to standard care could prevent severe outcomes in patients with a dangerous C. difficile gut infection. It focused on 44 patients identified as high-risk using a special score based on their genes, blood tests, and gut bacteria. The goal was to see if this personalized approach could reduce organ failure, relapse, or death within 40 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLOSTRIDIOIDES DIFFICILE INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki
Thessaloniki, 54621, Greece
-
1st Department of Internal Medicine, General University Hospital of Ioannina
Ioannina, 45500, Greece
-
1st Department of Internal Medicine, THRIASIO General Hospital of Eleusis
Athens, 10918, Greece
-
1st University Department of Internal Medicine, LAIKO General Hospital of Athens,
Athens, 11527, Greece
-
1st University Department of Propaedeutic Surgery, IPPOKRATEION General Hospital
Athens, 11527, Greece
-
2nd Department of Internal Medicine, Thriasio General Hospital
Athens, 10918, Greece
-
2nd Department of Internal Medicine, Tzanneion General Hospital
Piraeus, 18536, Greece
-
2nd Department of Internal Medicine, University General Hospital of Alexandroupolis
Alexandroupoli, 68100, Greece
-
4th Department of Internal Medicine, Attikon University Hospital
Athens, 12462, Greece
-
Department of Internal Medicine, Larissa University Hospital
Larissa, 41334, Greece
-
Department of Internal Medicine, University General Hospital of Patras PANAGIA I VOITHIA
Pátrai, 26504, Greece
Conditions
Explore the condition pages connected to this study.